← All trials
NCT05574985
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 29, 2022
- Primary completion
- Oct 9, 2022
- Completion date
- Mar 31, 2023
- First posted
- Oct 12, 2022
- Last posted
- Nov 4, 2022
- Enrollment
- 272
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Lead sponsor
- Bengbu Medical CollegeCollaborator
- Bengbu Medical CollegeOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.